Developer and manufacturer of surgical sealants, Tissuemed has been cash generative for the first time in its history. The accounts for year ended March 31st 2017 show the Leeds-based company profiting from early success in China, together with growth in other targeted international markets.
Audited accounts can be found here.
Chairman Paul Banner, in a letter to shareholders, says; “…the Company is now in a much stronger position than it has ever been. Tissuemed is also in the unique position of having a true surgical sealant product registered for sale in China. In my view, this uniqueness has added a great deal of value to the Company.”